We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
-22.31%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
AUM
$139M
AUM Growth
-$88.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN icon
1
Biohaven
BHVN
$2.43B
$70.6M 50.84%
2,936,507
CYTK icon
2
Cytokinetics
CYTK
$10.8B
$39.4M 28.38%
980,392
BCRX icon
3
BioCryst Pharmaceuticals
BCRX
$2.52B
$28.8M 20.78%
3,846,154
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$74 ﹤0.01%
3,700

Similar funds

RP Management's Q1 2025 Portfolio in Review

As of Q1 2025, RP Management held 4 positions worth $139M, down 39% from $228M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. RP Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RP Management's ten largest holdings make up 100% of its $139M portfolio in Q1 2025.
  • RP Management opened 0 new positions and closed 0 in Q1 2025.
  • RP Management's portfolio value fell 39% quarter-over-quarter to $139M.

Based on RP Management's 13F filing for Q1 2025, filed 2 May 2025.